期刊名称：GENETIC TESTING AND MOLECULAR BIOMARKERS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Genetic Testing and Molecular Biomarkers is the leading peer-reviewed journal covering all aspects of genetic testing including molecular biomarkers. This journal is a forum for the development of new technology; the application of testing to decision making in an increasingly varied set of clinical situations; ethical, legal, social, and economic aspects of genetic testing; and issues concerning effective genetic counseling.
With more than 3,000 genes identified, and over 4,000 diseases caused by genetic defects, genetic testing has become an increasingly important part of medical practice. For many inherited diseases, genetic testing provides the definitive diagnosis. GTMB is the definitive resource for molecular geneticists, genetic counselors, researchers, clinicians, and scientists who develop, perform, and interpret genetic tests and their results.
Topics covered include:
*Diagnosis across the life span
*Risk assessment
*Carrier detection in individuals, couples, and populations
*Novel methods and new instrumentation for genetic testing
*Results of molecular, biochemical, and cytogenetic testing
*Genetic counseling
*Ethical, legal, and economic issues
Indexed/Abstracted in:
MEDLINE; Current Contents/Life Sciences; Current Contents/Clinical Medicine; EMBASE/Excerpta Medica; Science Citation Index Expanded; BIOSIS Previews; Biotechnology Citation Index; Biological Abstracts; EMBiology; Scopus; CAB Abstracts
Instructions to Authors
Genetic Testing and Molecular Biomarkers publishes original papers on all aspects of genetic testing, including prenatal diagnosis, risk assessment, clinical consequences of molecular genetics, results of population screens and targeted testing, methodologies, strategies and ethical and legal issues.
All new manuscripts must be submitted online at:
http://mc.manuscriptcentral.com/genetic-testing
Please read all the instructions to authors before submitting.
Manuscript Submission and Copyright Agreement Form
The Copyright Agreement form (available from web site at http://www.liebertpub.com/media/content/transfer_of_copyright.pdf.) should be submitted once your paper has been accepted for publication. Manuscripts cannot be published without this form. The corresponding author is responsible for obtaining signatures of coauthors. Authors not permitted to release copyright must still return the form signed under the statement of the reason for not releasing the copyright. Upon acceptance of your paper, please fax the Copyright Agreement form to 914-740-2108.
PREPARATION OF MANUSCRIPT
Online submission of the manuscript is required, in either PC (preferred) or Macintosh format, preferably in Microsoft Word or Word Perfect.
The manuscript should be double-spaced with a minimum 1.25 inch margin. On the first page, give the title of the paper, name(s) of the author(s), and institutional affiliations(s). Please also indicate the corresponding author and full contact information, including e-mail address, and supply a running title of about 45 characters. On the second page, supply an Abstract of about 200 words, stating the aims, results, and conclusions. Subsequent pages should provide the following in sequence: Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, tables, and figure legends. Number pages consecutively. The first author’s last name should appear on each page. A separate page should include the full mailing address and contact information (telephone, fax, and e-mail address) for each author listed on the title page. Authors should also include the names, affiliations, and e-mail addresses of at least 3 reviewers. Please follow this protocol to avoid delay in processing. Please bear in mind that Genetic Testing and Molecular Biomarkers will not accept case reports or case studies of any kind. Please do not submit them as original articles.
TABLES AND ILLUSTRATIONS
Prepare each table with its caption in a separate file. Use arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.
The Journal will publish color photographs, but the author will be charged for the cost of color separations and printing. The Publisher will provide the author with a more precise cost estimate when the figures are received. For further details, contact the Editor or Publisher.
Please follow these guidelines for submitting figures:
- Do NOT embed art files into a Word or PDF document. Figures provided in this format cannot be used for production purposes.
- Line illustrations should be submitted at 600 dpi.
- Halftones and color should be submitted at a minimum of 300 dpi.
- Save as either TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process. To ensure proper print quality, please submit only TIFF or EPS files.
- Color art must be saved as CYMK - not RGB. (NB: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur.)
- Black and white art must be submitted as grayscale �not RGB.
- Do NOT submit PowerPoint, PDF, Bitmap or Excel figure or table files. When naming your figure and table files, please label them with the main author’s last name, followed by a period (.), and then list the figure number. Ex: Smith.Fig1; Smith.Table1. Label figures and tables inside the files in addition to naming the file with the figure or table number. (ie: When figures or table files are opened, the figure or table number should appear inside the file.)
In order to expedite your submission as quickly and efficiently as possible we ask that all artwork be checked using Digital Expert before submitting. This is a free tool that will ensure that you prepare and submit quality digital materials suitable for print.
Go to http://dx.sheridan.com to check your image files.
You will be given directions on how to correct any files which do not pass.
REMINDER
PLEASE ENSURE THAT YOUR MAIN MANUSCRIPT TEXT FILE
CONTAINS THE FOLLOWING:
- A title page which includes the title of the paper, as well as ALL author’s names, affilliations, e-mail addresses, and contact information.
- An abstract (uploading your abstract into the appropriate field in Manuscript Cental will NOT automatically incorporate it into the text file, so, please include the abstract within the manuscript file).
- References section correctly formatted (see examples).
- Tables and figures should be uploaded as individual files.
- Do NOT upload a PDF of your text file.
ADDITIONAL INFORMATION ABOUT ART FILES
Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
- All files should be scanned at 100% size.
- 300 dpi
- Final color mode: CMYK
- save file as: .tif or .eps
If you need directions on how to convert a Power Point slide to acceptable format go to http://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf
IMPORTANT:
Please upload individual files of all manuscript material ，do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
REFERENCES
Within the text, all references should be cited by authors and dates. Reference citations are not permitted in the abstract of a paper. If more than two authors are involved, use et al. after the first author’s name. If several papers by the same authors in the same year are cited in one sentence, use a lower case letter designation to indicate the individual papers. (Dunn and Studier, 1973a, 1973b). Use the same designation in the reference list. In the References section, each item should be double-spaced and listed in alphabetical order at the end of the paper. Each reference should include all authors‘names and the complete title of the cited paper. If more than three authors are involved, use et al. after the third author’s name. When data from an unpublished source are given, supply the researcher‘s name. If the work is in press, give the journal in which it is to be published or the name of the publisher. Abbreviation of journal names should follow the style of MEDLINE.
In the References list, citations should include all authors and the complete title in the following style (as in the American Journal of Human Genetics):
Journal article:
Lagoe E, LaBella S, Arnold G, et al. (2005) Cystic fibrosis newborn screening: A pilot study to maximize carrier screening. Genet Test 9:255-60.
Book:
Peters DJM, Sandkuijl LA (1992) Genetic heterogeneity of polycystic kidney disease in Europe. In: Breuning MH, Devoto M, Romeo G (eds) Contributions to nephrology: Polycystic kidney disease. Karger, Basel, pp 128-39.
ISCLOSURE STATEMENT
Immediately following the Acknowledgments section, include a section entitled Author Disclosure Statement.
In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision.
Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.
If no conflicts exist, the authors must state ˜No competing financial interests exist.“
PERMISSIONS
The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure should read, “reprinted by permission from Jones et all and list the appropriate reference. All permissions listings must be shown in the manuscript，they cannot be entered on proofs. Manuscripts submitted to this Journal must not be under consideration elsewhere.
REPRINTS
Reprints may be ordered by using the special reprint order form that will accompany the proofs. Reprints ordered after the issue is printed will be charged at a higher rate.
PUBLISHER
Genetic Testing and Molecular Biomarkers is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740-2100; fax; (914) 740-2101; e-mail: info@liebertpub.com internet: www.liebertpub.com; www.liebertpub.com
Editorial Board
Editor-in-Chief
Kenneth I. Berns, MD, PhD
Director
UF Genetics Institute
PO Box 103610
College of Medicine
Gainesville, FL 32610-3610
352-273-8100
Fax 352-273-8284
kberns@ufl.edu
Editorial Board
Sharon Adams MT, CHS (ABHI)
National Institutes of Health
Bethesda, MD
William Allen, JD
University of Florida College of Medicine
Gainesville FL
Zilfalil bin Alwi, MBBS, MMed, PhD
Universiti Sains Malaysia
Kota Bharu, Kelantan, Malaysia
Paolo Arosio, PhD
Universita` di Brescia
Brescia, Italy
Deborah Bowen, PhD
Boston University
Boston, MA
Mark Brantly, MD
University of Florida
Gainesville, FL
Martijn Breuning, PhD
Leiden University Medical Center
Leiden, The Netherlands
Michele Caggana, ScD
NYSDOH Wadsworth Center
Albany, NY
Marilyn Dumont-Driscoll, MD, PhD
University of Florida College of Medicine
Gainesville, FL
Rob Elles, PhD, FRCPath
St Mary's Hospital
Manchester, UK
Terry Flotte, MD
University of Massachusetts Medical School
Worchester, MA
Steven Ghivizzani, PhD
University of Florida College of Medicine
Gainesville, FL
Jackie Hobbs, MD,PhD
University of Florida College of Medicine
Gainesville, FL
Haig Kazazian, MD
University of Pennsylvania Medical School
Philadelphia, PA
Anita Kinney, PhD, RN
Huntsman Cancer Institute
Salt Lake City, UT
Daman Kumari, PhD
National Institutes of Health
Bethesda, MD
Elaine Lyon, PhD
University of Utah School of Medicine
Salt Lake City, UT
Donald Miller, MD,PhD
University of Louisville
Louisville, KY
Peter O'Leary, PhD
Office of Population Health Genomics
Perth, Western Australia
Linda Pasztor PhD, FACMG
Sonora Quest Laboratories
Tempe, AZ
Pradyumna Phatak, MD
Rochester General Hospital
Rochester, NY
Rivka Dresner-Pollak, MD
Hadassah-Hebrew University Medical Center
Jerusalem, Israel
Victoria Pratt, PhD, FACMG
Quest Diagnostics
Chantilly, VA
John Quillin, PhD, MPH, CGC
Virginia Commonwealth University
Richmond, VA
Alberto Riva, PhD
University of Florida College of Medicine
Gainesville, FL
Silvano Riva, PhD
Istituto Genetica Molecolare-CNR
Pavia, Italy
Jean Rommelaere, PhD
German Cancer Research Center
Heidelberg, Germany
Paul Rothberg, PhD
University of Rochester Medical Center
Rochester, NY
Paul H. Roy, PhD
Centre de recherche en infectiologie du CHUL
Québec Canada
Sharon F. Terry, MS
Genetic Alliance
Washington, DC
Peter Tijssen, PhD
University of Quebec
Quebec, Canada
Gilberto Vargas-Alarcon, PhD
Instituto Nacional de CardiologÃa Ignacio Chávez
Tlalpan, Mexico
Peggy Wallace, PhD
University of Florida College of Medicine
Gainesville, FL
Janet Williams, PhD
University of Iowa
Iowa City, IA
Jean Amos Wilson, PhD
Focus Diagnostics
Cypress, CA
Chun Zhang, Ph.D.
Institute of Medical Biology, CAMS
Yunnan, China
Founding Editor
Fred Gilbert, M.D.
Weill Medical College of Cornell University
|
